A Prospective, Randomized Trial of Intravenous Pulse Versus Sequential Steroid Therapy for Patients With Graves' Orbitopathy

Graves' Ophthalmopathy Clinical Trial

Official title:
A Randomized Trial of Intravenous Pulse Versus Sequential Steroid Therapy for Patients With Graves' Orbitopathy

Status Recruiting

Clinical Trial Summary

This study was designed to compare the efficacy and safety of 4.5g iv MP administered in 12 weeks and 4 weeks.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01969019
Study type	Interventional
Source	Ruijin Hospital
Contact	Ning Guang, Professor
Phone	(8621)64370045
Email	guangning@medmail.com.cn
Status	Recruiting
Phase	Phase 4
Start date	January 2010
Completion date	October 2013

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02059655` - Prostaglandin F2-alpha Eye Drops in Thyroid Eye Disease (Bima Study)	Phase 4
Completed	`NCT02721992` - Graves' Orbitopathy and Hypercholesterolemia	N/A
Recruiting	`NCT02290704` - Retinal Oxygen Saturation in Patients With Graves' Ophthalmopathy and in Normal People	N/A
Recruiting	`NCT01056419` - The Effect of Early Total Thyroidectomy in the Course of Graves' Orbitopathy	Phase 4
Completed	`NCT00697528` - Color Doppler Imaging of Orbital Venous Flow in Grave's Orbitopathy	N/A
Recruiting	`NCT00174057` - The Role of TSH Receptor, PPAR-r, IGF-1R, IGF and Cytokines in Different Stages of Graves’Ophthalmopathy	N/A
Completed	`NCT00430547` - Thyroid-Associated Ophthalmopathy Subtypes and Orbital Antibodies	N/A
Completed	`NCT03922321` - Study of RVT-1401 for the Treatment of Patients With Moderate to Severe Active Graves' Ophthalmopathy (GO)	Phase 2